FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/05/2022
Voltar para busca
Dado oficial do USPTO
MERLIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
24/05/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
26/10/2020
Data de registro
09/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/11/2021
Última transação
09/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
78
Localização do titular
NL
Examinador
RUTLAND, BARBARA A
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SkylineDx B.V.
Representantes
James C. Watson TraskBritt, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substancessuch as bone marrow samplesblood sampleson human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagentsinter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detectionnamely oncology; predictive test reagentsin search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparationsfor medical purposesfor the testing of blood and human or animal tissueincluding cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical usenamely medical diagnostic reagents and assays for testing of tissue for use in disease detectionnamely oncology; preparations for detecting mutation in human genes for medical purposes
Classe 42
Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological researchclinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the fields of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer
Classe 44
Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testingmonitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2022
FIMP
FINAL DISPOSITION PROCESSED
01/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/08/2021
PUBO
PUBLISHED FOR OPPOSITION
24/08/2021
GPNX
NOTIFICATION PROCESSED BY IB
22/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/08/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2021
RFNT
REFUSAL PROCESSED BY IB
25/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/04/2021
RFRR
REFUSAL PROCESSED BY MPU
06/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/03/2021
CNRT
NON-FINAL ACTION WRITTEN
30/03/2021
DOCK
ASSIGNED TO EXAMINER
26/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/01/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/01/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MERLIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.